Advertisement Health Canada approves Next Pharmaceuticals' Relora - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Health Canada approves Next Pharmaceuticals’ Relora

Health Canada, the country's Federal department, has issued NPN 505349 for Next Pharmaceuticals' Relora, allowing the company to sell all-natural dietary supplement throughout Canada.

Relora is a powder used in capsule form for oral administration and alleviates stress, stress-related eating and improves weight management by quieting the hypothalamic-pituitary-adrenal axis without causing drowsiness.

The key ingredients of Relora include a blend of Magnolia officinalis and Phellodendron amurense bark extracts, which are used in traditional Chinese medicine.

Honokiol and Berberine help in reducing stress and anxiety without sedative side effects when compared to prescription drugs.

Companies located in Canada can purchase Relora through Next Pharmaceuticals’ exclusive distributor, EnZed Nutricorp, according to Next Pharmaceuticals.